Clinical Trials in the Pharmaceutical Industry (Face-to-Face – December 2022)

You are registering to attend Clinical Trials in the Pharmaceutical Industry: Designing and Managing Phases I, II, and III on December 12-13, 2022.

This intermediate course explores the three key phases of clinical development of pharmaceuticals and addresses the skills needed to effectively and safely conduct global clinical trials. Presentations and workshops address the functions and critical decisions made through the clinical development process, from First in Human (FIH) to submission of a New Drug Application (NDA) or Biologics License Application (BLA). In addition to exploring Phases I-III, this course discusses regulatory guidelines, pharmacovigilance, statistical concepts, good clinical practices (GCP), and key roles and responsibilities. Over the course of three days, PERI expert faculty presents key factors to consider in the daily operations aspects of clinical trial conduct, organizational tips, resource planning ideas, financial implications, timeline concerns, regulatory implications, and cross-function communication.

Early Registration ends Friday, November 5, 2022.

Please allow up to 24 hours to receive your official course registration confirmation.